Literature DB >> 30937833

Prevalence of antiphospholipid antibodies among patients with chronic thromboembolic pulmonary hypertension.

Andrea Cervi1, James Demetrios Douketis2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30937833     DOI： 10.1007/s11739-019-02078-4

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  13 in total

1.  Severe digital necrosis as the clinical onset of antiphospholipid syndrome.

Authors:  José Antonio Vargas-Hitos; José Mario Sabio; Nuria Navarrete-Navarrete; Mónica Zamora-Pasadas; Juan Jiménez-Alonso
Journal:  Intern Emerg Med       Date:  2015-10-22       Impact factor: 3.397

2.  Thrombotic risk factors in pulmonary hypertension.

Authors:  M Wolf; C Boyer-Neumann; F Parent; V Eschwege; H Jaillet; D Meyer; G Simonneau
Journal:  Eur Respir J       Date:  2000-02       Impact factor: 16.671

Review 3.  Diagnosis and Management of the Antiphospholipid Syndrome.

Authors:  David Garcia; Doruk Erkan
Journal:  N Engl J Med       Date:  2018-05-24       Impact factor: 91.245

Review 4.  The pathogenesis of the antiphospholipid syndrome.

Authors:  Bill Giannakopoulos; Steven A Krilis
Journal:  N Engl J Med       Date:  2013-03-14       Impact factor: 91.245

5.  Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension.

Authors:  Chieh L Wong; Richard Szydlo; Simon Gibbs; Mike Laffan
Journal:  Blood Coagul Fibrinolysis       Date:  2010-04       Impact factor: 1.276

6.  Residual emboli on lung perfusion scan or multidetector computed tomography after a first episode of acute pulmonary embolism.

Authors:  Benilde Cosmi; Mathilde Nijkeuter; Massimo Valentino; Menno V Huisman; Libero Barozzi; Gualtiero Palareti
Journal:  Intern Emerg Med       Date:  2011-04-03       Impact factor: 3.397

Review 7.  The pathophysiology of chronic thromboembolic pulmonary hypertension.

Authors:  Gérald Simonneau; Adam Torbicki; Peter Dorfmüller; Nick Kim
Journal:  Eur Respir Rev       Date:  2017-03-29

Review 8.  Chronic Thromboembolic Pulmonary Hypertension. Epidemiology and Risk Factors.

Authors:  Marion Delcroix; Kim Kerr; Peter Fedullo
Journal:  Ann Am Thorac Soc       Date:  2016-07

9.  Epidemiology of chronic thromboembolic pulmonary hypertension in Korea: results from the Korean registry.

Authors:  So Young Park; Sang Min Lee; Jong Wook Shin; Byoung Whui Choi; Hojoong Kim; Jae Seung Lee; Sang Do Lee; Sung Soo Park; Hwa Sik Moon; Yong Bum Park
Journal:  Korean J Intern Med       Date:  2016-01-27       Impact factor: 2.884

10.  Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.

Authors:  Vittorio Pengo; Gentian Denas; Giacomo Zoppellaro; Seena Padayattil Jose; Ariela Hoxha; Amelia Ruffatti; Laura Andreoli; Angela Tincani; Caterina Cenci; Domenico Prisco; Tiziana Fierro; Paolo Gresele; Arturo Cafolla; Valeria De Micheli; Angelo Ghirarduzzi; Alberto Tosetto; Anna Falanga; Ida Martinelli; Sophie Testa; Doris Barcellona; Maria Gerosa; Alessandra Banzato
Journal:  Blood       Date:  2018-07-12       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.